Matthew Ferguson - Sep 21, 2023 Form 4 Insider Report for ELUTIA INC. (AZYO)

Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Matthew Ferguson
Stock symbol
AZYO
Transactions as of
Sep 21, 2023
Transactions value $
$0
Form type
4
Date filed
9/21/2023, 04:50 PM
Previous filing
Mar 9, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZYO Class A Common Stock Award +70.1K +138.81% 121K Sep 21, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AZYO Warrants (rights to buy) Award +105K 105K Sep 21, 2023 Class A Common Stock 105K $1.43 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within the 70,053 Units purchased by the reporting person for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock and one warrant to purchase one and one-half shares of Class A Common Stock.
F2 Includes 901 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
F3 The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028.